Ocular Therapeutix OCUL Operating Cash Flow
Operating Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Ocular Therapeutix in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.
The official record: Ocular Therapeutix’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ocular Therapeutix's operating cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ocular Therapeutix's operating cash flow?
- Ocular Therapeutix (OCUL) reported operating cash flow of -$65.99M in Q1 2026.
- How has Ocular Therapeutix's operating cash flow changed year-over-year?
- Ocular Therapeutix's operating cash flow decreased by 47.7% year-over-year, from -$44.67M to -$65.99M.
- What is the long-term trend for Ocular Therapeutix's operating cash flow?
- Over 4 years (2021 to 2025), Ocular Therapeutix's operating cash flow has grown at a 33.0% compound annual growth rate (CAGR), from -$65.55M to -$204.88M.
- What does operating cash flow mean?
- Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.